Gastric infection by helicobacter pylori and antral gastritis in Hyperglycemic obese and in diabetic subjects

New Microbiologica

Volumn 19, Issue 2, 1996, Pages 149-154

  Perdichizzi, G ^a   Bottari, M ^a   Pallio, S ^a   Fera, M T ^a   Carbone, M ^a   Barresi, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; BODY WEIGHT; FEMALE; GASTRITIS; GLUCOSE BLOOD LEVEL; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HYPERGLYCEMIA; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; STOMACH MUCOSA;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; OBESITY; TRIGLYCERIDES;

EID: 0030118803     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. BERGSTROM, B., LILIJA, B., OSTERLIN, S., and SUNDWIST, A, (1990). Autonomic neuropathy in non-insulin dependent (type II) diabetes mellitus possible influence of obesity. Journal of Internal Medicine 227, 57-63.
2. BOLONDI, L., BARTOLETTI, M., SANTI, V., COLETTI, G.C., GAIANI, S., and LABO, G. (1985). Measurement of gastric emptying time by realtime ultrasonography. Gastroenterology 89, 752-759.
3. BRYAN, C.S., REYNOLDS, K.L., and METZGER, W.T. (1985). Bacteremia in diabetic patients: comparison of incidence and mortality with non diabetic patients. Diabetes Care 8, 244-249.
4. CONTI-NIBALI, S., SFERLAZZAS, C., FERA, M.T., SAITTA, G., TEDESCHI, A., and MAGAZZÙ, G. (1990). Helicobacter pylori infection: a simplified diagnostic approach. The American Journal of Gastroenterology 85, 1573-1575.
5. GRAHAM, D.Y., and KLEIN, P.D. (1987). Campylobacter pyloridis gastritis: the past, the present and speculation about the future. The American Journal of Gastroenterology 82, 283-286.
6. HOROWITZ, M., HARDING, P.E., MADDOX, A.F., WISHORTZ, J.M., AKKERMANS, L.M.A.A., CHATTERTAN, B.E., and SHEARMAN, D.J.C. (1989), Gastric and aesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 32, 151-159.
7. HOSTETTER, M.K. (1990). Handicaps to host defense: effects of hyperglycemia on C3 and Candida albicans. Diabetes 39, 271-275.
8. LAMBERT, J.R., DUNN, K.L., TURNER, H., and KORMAN, M.G. (1986). Effect on histological gastritis following eradication of Campylobacter pyloridis. Gastroenterology 90, 1509.
9. LEE, A., FOX, J., and HAZELL, S. (1993). Pathogenicity of Helicobacter pylori: a perspective. Infection and Immunity 61, 1601-1610.
10. LOFFELD, R.J.L.F., STOBBERINGH, E., FLENDRIG, J.A., SPREEUWEL, J.P. and VAN ARENDS, J.W. (1989). Diagnostic value of an immunoassay to detect anti Campylobacter pylori antibodies in non-ulcer dispepsia. Lancet i, 1182-1185.
11. MARSHALL, B. J. (1994). Helicobacter pylori. The American Journal of Gastroenterology 89, S116-S128.
12. MARSHALL, B.J., MEGECHIE, D.B., ROGERS, P.A., and GLANCY, R.J. (1985). Pyloric campylobacter infection and gastroduodenal disease. Medicine Journal of Australia 142, 439-444.
13. MACKINLAY, A.W., UPADHYAY, R., GEMMEL, C.G., and RUSSEL, R.I. (1990). Helicobacter pylori: bridging the credibility gap. Gut 31, 940-945.
14. MEUNIER, F., KIEHN, T.E., and ARMSTRONG, D. (1981). Fungemia in the immunocompromised host: changing pattern, antigenemia, high mortality. American Journal of Medicine 71, 363-370.
15. MORRIS, A., and NICHOLSON, G. (1987). Ingestion of Campylobacter pylori causes gastritis and raised fasting gastric pH. The American Journal of Gastroenterology 82, 192-199.
16. PRICE, A.B. (1991). The Sydney System: histological division. Journal of Gastroenterology and Hepatology, 6, 209-222.
17. RAUWS, A.J., LANGENBERG, W., HOUTHOFF, H.J., ZANEN, H.C., and TYTGAT, G.N.J. (1988). Campylobacter pyloridis associated chronic active antral gastritis, a prospective study of its prevalence and the effects of antibacterial and anti-ulcer treatment. Gastroenterology 94, 33-40.
18. RAYFIELD, E.J., AULT, M.J., KEUSCH, G.T., BROTHERS, M.J., NECHEMIAS, C., and SMITH, H. (1982). Infection and diabetes: the case for glucose control. American Journal of Medicine 72, 439-450.
19. SIURALA, M., SIPPONEN, P., and KEKKI, M. (1988). Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut 29, 909-915.
20. SLOMIANY, B.L., BILSKI, J., SAROSIEK, K., MURTY, V.L.N., DVOORKIN, B., VANHORN, K., ZIELENSKI, J., and SLOMIANY, A. (1987). Campylobacter pyloridis degrades mucin and undermines gastric mucosal integrity. Biochemical Biophysical Research Communications 144, 307-314.
21. WARREN, J.R., and MARSHALL, B.J. (1983). Unidentified curved bacilli on gastric epithelium in active chronic gastritis, Lancet i, 1273-1275.
22. WHEAT, L.J. (1980). Infection and diabetes mellitus. Diabetes Care 3, 187-197.
23. WORLD HEALTH ORGANIZATION STUDY GROUP. Diabetes Mellitus (WHO Technical Report Series No. 727) (1985). Geneva. World Health Organization.